Théodore J. Lampidis

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 509 citations

Oncology, 2-Deoxy-d-glucose Alone, Medicine +8

2-Deoxy-<scp>d</scp>-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers <b> <i>In Vivo</i> </b>

Gregory Maschek, Niramol Savaraj, Waldemar Priebe et al. · Cancer Research · 2004 · 440 citations

Osteosarcoma Cells, Tumor Biology, Metronomic Therapy +16

Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.

Ian C. Summerhayes, Théodore J. Lampidis, Samuel D. Bernal et al. · Proceedings of the National Academy of Sciences · 1982 · 370 citations · Full text

Carcinoma Cells, Pathology, Mitochondrial Biology +19

Under normoxia, 2-deoxy-<scp>d</scp>-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

Metin Kurtoğlu, Ningguo Gao, Jie Shang et al. · Molecular Cancer Therapeutics · 2007 · 239 citations

Selective toxicity of rhodamine 123 in carcinoma cells in vitro.

Théodore J. Lampidis, Samuel D. Bernal, Ian C. Summerhayes et al. · PubMed · 1983 · 235 citations

Mitochondrial-specific Fluorescent Dye, Mitochondrial Function, Oncogenic Agent +15